CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of October 19, 2026, CGON trades at $59.98 with a market cap of $5.31B and a P/E ratio of -23.50. CGON moved +0.32% today. Year to date, CGON is +43.48%; over the trailing twelve months it is +44.62%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $92.56. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CGON, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $59.98 |
| Market Cap | $5.31B |
| P/E Ratio | -23.50 |
| EPS | $-2.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $80.97 |
| 52-Week Low | $14.80 |
| Volume | 986.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $6.23M |
| Net Income | $-224.38M |
| Gross Margin | 0.00% |
10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $92.56.